Home › Colorectal Cancer › Colorado › Loveland
Colorectal Cancer clinical trials in Loveland, CO
3 studies for Colorectal Cancer are looking for participants at sites in and around Loveland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Vanguard Study: Testing a New Way to Screen for Cancer
RecruitingHealthy volunteers welcome
- Medical Center of the Rockies, Loveland
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Medical Center of the Rockies, Loveland
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Banner MD Anderson Cancer Center at North Colorado Medical Center - Loveland Campus, Loveland
- Banner North Colorado Medical Center - Loveland Campus (Hospital), Loveland
About Colorectal Cancer
Colorectal cancer starts in the colon or rectum. It may not cause symptoms at first. Screening tests can help find it early, when treatment is most effective.
More about Colorectal Cancer on MedlinePlus
Colorectal Cancer trials in other cities
- Houston, TX102 studies
- New York City, NY78 studies
- Nashville, TN69 studies
- Boston, MA63 studies
- Los Angeles, CA59 studies
- Arlington, VA52 studies
- St. Louis, MO50 studies
- San Antonio, TX46 studies
- Philadelphia, PA44 studies
- Grand Rapids, MI40 studies
- Baldwin Park, CA37 studies
- Chicago, IL34 studies
Other studies in Loveland
- Lung Cancer7 studies
- Breast Cancer7 studies
- Non-Small Cell Lung Cancer5 studies
- Prostate Cancer5 studies
- Bladder Cancer4 studies
- Ovarian Cancer4 studies
- Aortic Valve Stenosis4 studies
- Colon Cancer3 studies
- Metastatic Cancer3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.